Ajanta Pharma informs about company updates

09 Feb 2017 Evaluate

Ajanta Pharma has informed that the Company’s Paithan facility was recently inspected by US FDA and the Company has issued one procedural related 483. The Company is in process of responding to the same within the stipulated time prescribed by US FDA.

The above information is a part of company’s filings submitted to BSE.

Ajanta Pharma Share Price

2917.50 147.25 (5.32%)
01-Jan-2026 14:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.25
Dr. Reddys Lab 1250.80
Cipla 1499.60
Zydus Lifesciences 913.40
Lupin 2101.75
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×